Cases 1 - 10 of 57
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2023cv01219
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2023cv01193
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Counter Claimant:
Eugia Pharma Specialities Ltd.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al
as 1:2023cv00582
Plaintiff:
Vertex Pharmaceuticals Incorporated
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities, Ltd. et al
as 1:2022cv01611
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Defendant:
Eugia Pharma Specialities, Ltd., Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. Aurobindo Pharma Limited et al
as 1:2022cv01114
Plaintiff:
Eli Lilly & Company, Incyte Corporation, Incyte Holdings Corporation and others
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00971
Plaintiff:
Covis Pharma GmbH, AMAG Pharma USA, Inc. and AMAG Pharmaceuticals, Inc.
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00911
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceutical Company Ltd.
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al
as 1:2022cv00728
Plaintiff:
Vertex Pharmaceuticals Incorporated
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan, Inc. v. Aurobindo Pharma Limited et al
as 1:2021cv01808
Plaintiff:
Allergan, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Limited
Cause Of Action: 35 U.S.C. § 271
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
